SBC Medical Group Holdings Incorporated Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
SBC Medical Group Holdings Incorporated (SBC) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2026-06-30 was 0.00 shares.
- SBC Medical Group Holdings Incorporated share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2026-03-31 was 0.00 shares.
- SBC Medical Group Holdings Incorporated share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-12-31 was 0.00 shares.
- SBC Medical Group Holdings Incorporated share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-09-30 was 0.00 shares.
- SBC Medical Group Holdings Incorporated share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- SBC Medical Group Holdings Incorporated share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2024 was 449.19K shares, a 74.78% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2023 was 1.78M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 0.00 shares 10-Q · filed 2026-08-13 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-13 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-14 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-14 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-27 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-13 | 0.00 shares 10-K · filed 2026-03-27 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-13 | 0.00 shares 10-Q · filed 2025-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 0.00 shares 10-Q · filed 2026-08-13 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-13 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-14 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-14 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-27 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-27 | 449.19K shares 10-K · filed 2026-03-27 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-14 | 449.19K shares 10-Q · filed 2025-11-14 | 449.19K shares derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 449.19K shares 10-Q · filed 2025-08-13 | 449.19K shares derived: sum of 3 quarters · filed 2025-08-13 | |
| 2024-03-31 | 449.19K shares 10-Q · filed 2025-05-15 | 449.19K shares derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 1.78M shares 10-K · filed 2025-03-28 | ||
| 2023-09-30 | 1.78M shares 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |